mL385
Cat.No:IM1020 Solarbio
CAS:846557-71-9
Molecular Formula:C29H25N3O4S
Molecular Weight:511.59
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
NF-κB >
mL385CAS:846557-71-9
Molecular Formula:C29H25N3O4S
Molecular Weight:511.59
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 846557-71-9 |
Name | mL385 |
Molecular Formula | C29H25N3O4S |
Molecular Weight | 511.59 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | O=C(NC1=NC(C2=CC=C(N(C(C3=C(C)C=CC=C3)=O)CC4)C4=C2)=C(C)S1)CC5=CC(OCO6)=C6C=C5 |
InChIKey | LINHYWKZVCNAMQ-UHFFFAOYSA-N |
InChI | InChI=1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33) |
PubChem CID | 1383822 |
Target Point | Nrf2 |
Passage | NF-κB |
Background | mL385 is a novel and specific NRF2 inhibitor. |
Unit | Piece |
Specification | 5mg 10mM*1mL in DMSO 25mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Scutellarin attenuates oxidative stress and neuroinflammation in cerebral ischemia/reperfusion injury through PI3K/Akt-mediated Nrf2 signaling pathways
Click to check >>Author:Xie X; Wang F; Ge W; Meng X; Fan L; Zhang W; Wang Z; Ding M; Gu S; Xing X; Sun X.
IF:5.0000
Publish_to:European Journal of Pharmacology
PMID:37611841
Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Click to check >>Author:Wei Z; Pinfang K; Jing Z; Zhuoya Y; Shaohuan Q; Ch
IF:4.6000
Publish_to:Mediators Inflamm
PMID:37101595
Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Click to check >>Author:Zhang Wei, Kang pinfang, Zhou jing, Yao zhuoya, Qian Shaohuan, Shi Chao
IF:4.5290
Publish_to:MEDIATORS OF INFLAMMATION
PMID:37101595
Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway
Click to check >>Author:Li Fan, Hu Zhenfei, Huang Yidan, Zhan Haiting
IF:1.6000
Publish_to:Journal of Cardiothoracic Surgery
PMID:37430319